A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Working with a line of colon cancer cells, Korean researchers figured out a way to throw a few genetic switches to cause the ...

As one TikTok user explained on the platform, she noticed that her stools were thinner than normal, along with other red-flag ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...

New research describes the early steps of colorectal tumor formation and lays a foundation for improving diagnosis and ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Pfizer said Friday that the Food and Drug Administration approved its treatment for patients with metastatic colorectal cancer.

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...